Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 41,266Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Abacus Medicine A/S

02 1Atnahs Pharma Netherlands B.V.

03 2Atnahs Pharma Netherlands Bv.

04 1Atnahs Pharma Switzerland Ag

05 1Janssen-Cilag Ab

06 1LIPOMED GmbH

07 1Lipomed Ag

08 1Lipomed GmbH

09 5Lipomed Gmbh

10 1Merck (Switzerland) Ag

11 8Merck Europe B.V.

12 2Merck Europe Bv

13 3Orifarm AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Leustatin

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 10mg/10ml

Packaging :

Approval Date : 21/09/1998

Application Number : 52541

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Leustatin

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1mg/ml

Packaging :

Approval Date : 19/11/1993

Application Number : 19931119000026

Regulatory Info : Deregistered

Registration Country : Sweden

blank

03

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Litak

Dosage Form : Cladribine 10Mg 5Ml 5 Units Parenteral Use

Dosage Strength : 5 VIALS SC 10 mg 5 ml 2 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Litak

Dosage Form : Injectable Solution

Dosage Strength : 2mg/ml

Packaging :

Approval Date : 14/04/2004

Application Number : 20040414000016

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Litak

Dosage Form : Injection/Infusion Solution

Dosage Strength :

Packaging :

Approval Date : 03/11/1999

Application Number : 55172

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Mavenclad

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 22/08/2017

Application Number : 20160628000012

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribinum

Brand Name : Mavenclad®

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date : 01-07-2025

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

08

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribinum

Brand Name : Mavenclad®

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date : 01-07-2025

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

09

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Mavenclad

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 19/03/2019

Application Number : 66831

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

Atnahs Pharma Netherlands B.V.

Country
Paris Packaging Week
Not Confirmed
arrow

Atnahs Pharma Netherlands B.V.

Country
arrow
Paris Packaging Week
Not Confirmed

Cladribine

Brand Name : Leuject

Dosage Form : Injectable Solution

Dosage Strength : 2mg/ml

Packaging :

Approval Date : 08/01/2025

Application Number : 20230831000038

Regulatory Info : Approved

Registration Country : Sweden

blank